Medical Fee Revision: Both Medical Institution Revenue and Patient Out-of-Pocket Costs Expected to Rise – NHK News

News Highlights

The medical fee revision for fiscal year 2026 is expected to lead to an increase in both medical institutions' income and patients' out-of-pocket burden. This revision may affect medical institutions' management strategies and business succession. Specifically, points raised include maintaining facility standards through economies of scale, dispersing equipment investment burdens, and utilizing tax schemes including transitions to specific medical corporations and social medical corporations.

M&A Medical Editorial Department's Perspective

2026年度の診療報酬改定が、医療機関の収入増と患者負担増を同時に招くというNHKの報道は、経営者にとって無視できないシグナルです。単に収入が増えるという楽観論に浸るのではなく、この改定が「施設基準の維持・向上」や「設備投資の負担分散」といった、規模のメリットを追求するM&Aやグループ化を加速させる可能性を注視すべきです。例えば、地域の中核病院が、専門性の高い診療科の維持や最新医療機器導入のために、より規模の大きな医療法人グループへの参画を検討するケースが増えるかもしれません。さらに、特定医療法人や社会医療法人への移行を視野に入れた税務スキームの最適化も、事業承継戦略と一体で検討する必要性が高まります。この改定サイクルを、自院の経営戦略・承継戦略を見直す契機と捉えることが肝要です。

Points Raised by This News

• The medical fee revision may simultaneously lead to increased income for medical institutions and increased patient burden, impacting management decisions.
• The revision may accelerate M&A and group formation to maintain facility standards and disperse equipment investment burdens.
• Optimizing tax schemes with a view to transitioning to specific medical corporations or social medical corporations will be important.
• This serves as an opportunity to review mid-to-long-term management and succession strategies.

Practical Questions Arising from This News

• With this medical fee revision, which specific medical departments or services are targeted for increased income and burden?
• Considering our institution's size and regional characteristics, what kind of M&A or group formation would be most advantageous?
• What are the merits and demerits of transitioning to a specific medical corporation or social medical corporation, and is it suitable for our institution?

If You Feel "Should I Consult Too?"

With this medical fee revision, what changes can be anticipated in your institution's income structure and patient burden? Furthermore, could M&A or group formation leveraging economies of scale, or optimization of tax schemes, be effective options to respond to these changes? We recommend consulting with experts to formulate the optimal strategy with a view to your institution's future. Let's consider this concretely.

M&A Medical (CentralMedience Inc.) is a business succession support service for medical corporations, hospitals, and clinics, certified by the Small and Medium Enterprise Agency as an M&A support institution. We provide comprehensive support.Success FeeWe handle consultations with strict confidentiality.Contact Us for a Free Consultation